Carefully Selected News and Features About Metastatic Breast Cancer Research
Metastatic Trial Talk empowers you with knowledge about the latest clinical trials, research, and treatment options for you to share and discuss with your doctor.
- LATEST UPDATES>January 2026
Artificial Intelligence (AI) and MBC
AI (Artificial Intelligence) is being studied for its ability to improve clinical trials, predict response to treatment, and more. Read below to learn more about how AI may help...
Read more
New Clinical Trials For Stage IV Breast Cancer
New clinical trials for stage 4 breast cancer are available. See clinical trials for ER/PR Positive, Triple Negative, and other...
Read more
FDA Expands Approval for Enhertu®
The FDA expanded approval for fam-trastuzumab deruxtecan-nxki (Enhertu®) in combination with pertuzumab (Perjeta®) as first-line treatment of people with HER2+ MBC. Click to...
Read more
San Antonio Breast Cancer Symposium 2025
The San Antonio Breast Cancer Symposium (SABCS) recently held its 2025 conference from December 9-12, 2025. Click to read MBC-related reports from this...
Read more
Will I Get Paid if I Participate in a Clinical Trial for MBC?
Click to learn about money you may receive if you participate in a clinical trial, including whether you will be...
Read more
Experts Weigh in on MBC Subtypes: Triple Negative MBC, Including HER2-Low and HER2-Ultralow
This month, we highlight the latest expert opinions on treatments for triple negative and HER2-low and -ultralow MBC and unanswered questions that need to be answered in clinical...
Read more
Mark Your 2026 Calendars!
Click for a calendar of upcoming in-person, virtual, and hybrid MBC...
Read more
Clinical Trial Support for Spanish Speakers
Resources are available to help Spanish-speakers with MBC learn about clinical trials. Click to learn...
Read moreSEARCH OUR SITE
for past articles or specific information.